Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Presep and Vascath Interaction Study

This study has been terminated.
(Study stopped due to a lack of enrollment.)
Information provided by (Responsible Party):
arjun Bijoy chatterjee, Wake Forest School of Medicine Identifier:
First received: August 20, 2008
Last updated: April 29, 2016
Last verified: April 2016
This is a prospective, observational study to compare presep(tm) catheter central vein mixed venous oxygen saturation before and after dialysis is initiated via the vascath(tm) central venous dialysis catheter to evaluate device interaction.

Renal Dialysis

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: A Pilot Study to Compare the Interaction Between Central Venous Mixed Venous Oxygen Saturation Catheters and Central Venous Hemodialysis Catheters

Resource links provided by NLM:

Further study details as provided by Wake Forest School of Medicine:

Primary Outcome Measures:
  • change in SvO2 [ Time Frame: before and afer initiation of dialysis via a vascath ] [ Designated as safety issue: No ]

Estimated Enrollment: 100
Study Start Date: August 2008
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Detailed Description:
The central venous oxygen saturation catheter measurement may be influenced by close approximation to the tip of the central venous hemodialysis catheter when hemodialysis is ongoing.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
medical intensive care unit (MICU) patients in an academic tertiary care referral medical center.

Inclusion Criteria:

  • Admitted to the MICU
  • PreSep venous oxygen saturation central venous catheter already in place
  • VasCath central venous dialysis catheter already in place
  • Planned hemodialysis

Exclusion Criteria:

  • Patient unable to undergo hemodialysis
  • Contraindication for PreSep or VasCath catheters
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00739089

United States, North Carolina
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157
Sponsors and Collaborators
Wake Forest School of Medicine
Principal Investigator: Arjun B Chatterjee, MD, MS Wake Forest School of Medicine
  More Information

Responsible Party: arjun Bijoy chatterjee, Associate Professor of Medicine, Wake Forest School of Medicine Identifier: NCT00739089     History of Changes
Other Study ID Numbers: IRB00004073 
Study First Received: August 20, 2008
Last Updated: April 29, 2016
Health Authority: United States: Institutional Review Board

Keywords provided by Wake Forest School of Medicine:
renal dialysis
lactic acidosis

Additional relevant MeSH terms:
Systemic Inflammatory Response Syndrome
Pathologic Processes processed this record on October 28, 2016